IFITM3 restricts the morbidity and mortality associated with influenza
about
IFITM proteins restrict viral membrane hemifusion.Primordial germ cells in miceThe duck genome and transcriptome provide insight into an avian influenza virus reservoir speciesThe interferon-stimulated gene IFITM3 restricts West Nile virus infection and pathogenesisTherapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune ActivationDevelopment and Function of Protective and Pathologic Memory CD4 T CellsModeling Influenza Virus Infection: A Roadmap for Influenza ResearchModels of Respiratory Infections: Virus-Induced Asthma Exacerbations and BeyondThe Many Alternative Faces of Macrophage ActivationAn updated systematic review of the role of host genetics in susceptibility to influenzaEvolutionary conflicts between viruses and restriction factors shape immunityExercise Improves Host Response to Influenza Viral Infection in Obese and Non-Obese Mice through Different MechanismsTumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza VirusIFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusionSystems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivityIfitm3 limits the severity of acute influenza in miceThe role of viral, host, and secondary bacterial factors in influenza pathogenesisInfluenza virus activation of the interferon systemType I interferons in infectious diseaseCLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In VivoAerosol transmission is an important mode of influenza A virus spreadEngineering H5N1 avian influenza viruses to study human adaptationHIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashionE3 Ubiquitin Ligase NEDD4 Promotes Influenza Virus Infection by Decreasing Levels of the Antiviral Protein IFITM3Using Clinical Trial Simulators to Analyse the Sources of Variance in Clinical Trials of Novel Therapies for Acute Viral Infections.Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitinationZika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells.Accurate characterization of the IFITM locus using MiSeq and PacBio sequencing shows genetic variation in GalliformesWhy does pandemic influenza virus kill?Host genetic determinants of influenza pathogenicity.Impact of 2009 pandemic influenza among Vietnamese children based on a population-based prospective surveillance from 2007 to 2011An individualized predictor of health and disease using paired reference and target samples.Rhesus macaque IFITM3 gene polymorphisms and SIV infection.Ethical alternatives to experiments with novel potential pandemic pathogens.Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza virusesPhylogenetic evidence for a mild H1 pandemic in the early 1900s.Molecular determinants of influenza virus pathogenesis in mice.Innate immune sensing and response to influenza.The CCR5Δ32 allele is not a major predisposing factor for severe H1N1pdm09 infection.Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung.
P2860
Q21558779-212CA96B-925A-48B1-AEE8-42347F108189Q22065789-866DF578-CD19-45F5-89A9-486D9738B6F2Q22122074-1656BBAE-5BB4-48F9-A522-341EBFFAE858Q25708087-4D863602-0733-4788-9C82-6C7F60918CC6Q26775092-C5C919CD-5F1E-4747-A249-6328D6EA4D80Q26781324-74F4E8EC-B03C-4F42-A9BA-4FE6CC2D05E4Q26782421-0EFA47D1-69BA-4C79-A5B2-030B0FEF4F00Q26786359-54E62C48-935F-48A7-A249-7EF7B18EE817Q26800142-109C4211-B981-411E-BD18-3AC70EE2FE37Q27007082-A420F497-75FE-4ADD-BC46-59FE67012020Q27022032-FA94FCDE-E1C6-49B8-9949-CD4FEFF10DF4Q27304594-38A7A252-6FF6-413F-8D75-84DEA7AB6560Q27318631-59885A53-4014-4BE4-BD3F-7CE47AAEB463Q27329190-93A707C6-4339-4E85-96A3-CF27E39CA7E0Q27335125-6049E6A7-233C-4369-AABE-5F71B0456BE5Q27342563-A12E132E-05E4-43E0-93BA-588199E2201AQ28082144-E79A6427-AAF7-4F93-8C98-5C0CA7CCDDE2Q28088483-97684683-F4D3-4269-9741-4D9993A8ED94Q28255842-F8AED568-9835-41A6-915F-B7D134176689Q28354040-70C61BA5-CDFB-4BFA-8549-02F6E4C7F191Q28384397-9EC8D324-D396-44A9-9B5E-E6A4EEC054FEQ28386710-F63AE53D-F2CA-426B-9EC9-1C0E7D9624F0Q28389034-00610553-0A89-442B-9092-11E851287B7BQ28547141-49C22336-DBE4-4B8A-BE28-B1CC78403BF7Q28552030-6AACB123-E592-48B8-B1E6-65BCC21B7910Q28588118-436F20A9-390A-4757-B51E-E829FDFF09FEQ30145650-26CFD899-CAA1-4DB3-A7EC-0804C28C8E66Q30250922-B5C6D50A-BDBA-4D03-AF6E-556E2BBACA04Q30352613-3047E862-4A8E-4C76-B1FE-30F7EDF2B8DEQ30352727-FC6D00AB-7587-4F8A-8E8D-9FEFD66E792AQ30359851-5DF15106-F14D-470B-B198-E094035C9028Q30361306-823885FD-763D-493C-A42A-093A654D639BQ30361340-E8CC6EEA-B092-4859-89E8-1D4617407764Q30362738-F80F8479-FCF0-4DE6-A7F8-86FEC85261DDQ30363295-CB1446D7-EE0B-4FE5-A53E-CB3E40F72D45Q30363410-CDC3F9D0-A6E5-4A34-8F82-D6F19E83D31CQ30364868-FD0585BD-1BE1-4513-87C8-C6A7EAC98F8FQ30365302-BDED7D5D-0BE9-4B42-8EED-39E7A4FF0E63Q30365474-2BBE13B8-AAC6-4F75-8215-0A20BF80AFA4Q30366138-28E8881D-F065-49E3-AF56-2B57202BD0B6
P2860
IFITM3 restricts the morbidity and mortality associated with influenza
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
IFITM3 restricts the morbidity and mortality associated with influenza
@ast
IFITM3 restricts the morbidity and mortality associated with influenza
@en
IFITM3 restricts the morbidity and mortality associated with influenza
@en-gb
IFITM3 restricts the morbidity and mortality associated with influenza
@nl
type
label
IFITM3 restricts the morbidity and mortality associated with influenza
@ast
IFITM3 restricts the morbidity and mortality associated with influenza
@en
IFITM3 restricts the morbidity and mortality associated with influenza
@en-gb
IFITM3 restricts the morbidity and mortality associated with influenza
@nl
prefLabel
IFITM3 restricts the morbidity and mortality associated with influenza
@ast
IFITM3 restricts the morbidity and mortality associated with influenza
@en
IFITM3 restricts the morbidity and mortality associated with influenza
@en-gb
IFITM3 restricts the morbidity and mortality associated with influenza
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
IFITM3 restricts the morbidity and mortality associated with influenza
@en
P2093
Aaron R Everitt
Abraham L Brass
Christopher R Chin
David Goulding
David J Adams
Helen M Wise
Jennifer S Sims
Leanne Kane
Peter J Openshaw
Rachael S Wash
P2860
P2888
P304
P3181
P356
10.1038/NATURE10921
P407
P50
P577
2012-04-26T00:00:00Z
P6179
1031194819